Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Healthcare Biotechnology
Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United... see more

Recent & Breaking News (TSXV:MPH)

Medicure Reports First Quarter 2016 Financial Results

PR Newswire May 11, 2016

Medicure Files Application for New AGGRASTAT® Product Format

Canada NewsWire May 11, 2016

Medicure Announces Departure of President and Chief Operating Officer

Canada NewsWire May 9, 2016

Medicure to Announce Q1 2016 Financial Results on May 11, 2016

PR Newswire May 4, 2016

Medicure Announces Grant of Options

Canada NewsWire April 7, 2016

Medicure Announces Upcoming Conference Presentations

Canada NewsWire April 5, 2016

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2015

Canada NewsWire March 30, 2016

Medicure To Announce Fiscal Year 2015 Financial Results on March 30, 2016

Canada NewsWire March 23, 2016

Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference

Canada NewsWire February 23, 2016

Medicure to present at Cantech Investment Conference

Canada NewsWire January 21, 2016

Medicure Announces Preliminary Revenue For Fiscal 2015

Canada NewsWire January 11, 2016

Medicure announces ANDA collaboration with Apicore

PR Newswire January 6, 2016

Medicure Announces PDUFA Action Date for New Aggrastat Indication

Canada NewsWire December 2, 2015

Medicure Announces Grant of Stock Options

Canada NewsWire November 25, 2015

Medicure Reports Third Quarter 2015 Financial Results

Canada NewsWire November 9, 2015

Medicure Q3 Results and Conference Call Dates

Canada NewsWire November 3, 2015

PI Financial Initiates Coverage on Medicure Inc. with a $5.75 Target Price - Video Research Alert on InvestmentPitch.com

Newsfile October 20, 2015

IIROC Trade Resumption - Medicure Inc.

Newsfile September 10, 2015

Medicure Announces Filing of sNDA for New AGGRASTAT® Indication

PR Newswire September 10, 2015

IIROC Trade Halt - Medicure Inc.

Newsfile September 10, 2015